Clinical Trial Update: Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing vonoprazan-based non-bismuth triple therapy (standard or short course) or high-dose dual therapy against rabeprazole-bismuth …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AcipHex (rabeprazole) (rabeprazole)
• METRONIDAZOLE (Metronidazole)
• Takecab (vonoprazan) (vonoprazan)
• bismuth subcitrate (bismuth subcitrate)
• tetracycline (tetracycline)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: the Eradication Rates of Helicobacter Pylori | Phase 4 | Status: RECRUITING